← Open Payments lookup

DANIEL TINNEY: Open Payments

NPI 1780329110 · PARIS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,968 in 110 payments from 22 companies in 2025. Trend: 2023 $822 · 2024 $1,412 · 2025 $1,968

Food & beverage: $1,960Education: $8
CompanyPaymentsAmount
ABBVIE INC.23$369
Vanda Pharmaceuticals Inc.12$345
Supernus Pharmaceuticals, Inc.19$177
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$174
AstraZeneca Pharmaceuticals LP5$107
Teva Pharmaceuticals USA, Inc.5$99
Axsome Therapeutics, Inc.3$79
GlaxoSmithKline, LLC.4$77
Bayer Healthcare Pharmaceuticals Inc.4$64
Insulet Corporation3$63

Products named: VRAYLAR, HETLIOZ, CAPLYTA, Qelbree, FANAPT, FARXIGA, Auvelity, TRELEGY ELLIPTA.

Industry payments across KY — which companies pay providers there.